FDA approves new medication for chronic weight management, FDA (2023) Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: A mini-review, NIH (2022) Mounjaro- tirzepatide injection, Eli Lilly (2023) Mounjarotm (tirzepatide) injection, FDA (2022) Lillys tirzepatide shows additional 21.1% weight loss after 12 weeks of intensive lifestyle intervention, for a total mean weight loss of 26.6% from study entry over 84 weeks, Eli Lilly (2023) How to use Mounjaro, Eli Lilly (2023) Mounjaro dietary instructions, CNMRI (2023) Weekly exercise targets, American Diabetes Association (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

Why Side Effects Last Longer for Some People Side effects may persist longer if: Meals are large or high in fat Hydration is low Theres a sensitive digestive system There are underlying GI conditions The dose isnt well matched to the individual Adjustments to dosing, meal size, and hydration can often shorten how long symptoms last
Tew KD, Monks A, Barone L, Rosser D, Akerman G, Montali JA et al
(PubMed) Kennedy DO, Veasey R, Watson A, et al
This allows the body to reset its set pointthe weight the body naturally tries to maintain
No dramatic overnight transformation, just steady progress